Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan vs Dobutamine in Decompensated Heart Failure on Beta-Blockers
NCT00219388Phase 4Completed
- Sponsor
- Orion Corporation
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan in heart failure (HF), sponsored by Orion Corporation. Started Nov 2002; status: completed.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00219388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219388.